Meeting
2023 ASCO Annual Meeting
A phase I study of bintrafusp alfa and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic genitourinary (GU) malignancies.
Authors
Nicholas I. Simon
Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Nicholas I. Simon , Scot Anthony Niglio , Elias Chandran , Giovanni Maria Iannantuono , Salah Boudjadi , Rouf Banday , Daniel da Motta Girardi , Lisa M. Cordes , Lisa Ley , Sandeep Gurram , Andre Rashad Kydd , Jennifer C Jones , Kilian Elizabeth Salerno , Krishnan Patel , Vladimir Valera , Howard L. Parnes , William Douglas Figg , James L. Gulley , Jeffrey Schlom , Andrea B. Apolo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Urothelial Cancer - Advanced/Metastatic Disease
Clinical Trial Registration Number
NCT04235777
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4571)
DOI
10.1200/JCO.2023.41.16_suppl.4571
Abstract #
4571
Poster Bd #
63
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A phase I study of bintrafusp alfa (M7824) and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in adults with metastatic non-prostate genitourinary malignancies.
First Author: Scot Anthony Niglio
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A phase 1 trial of combined MEK, STAT3 and PD-1 inhibition in metastatic pancreatic ductal adenocarcinoma (PDAC).
First Author: Peter Joel Hosein
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Updated results of a phase 1 study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC; SGNS40-001).
First Author: Andrew L. Coveler
Poster
2021 ASCO Annual Meeting
Bosutinib in combination with pemetrexed in patients with selected metastatic solid tumors: A phase I study (NCT03023319).
First Author: Nagla Fawzy Abdel Karim